BIOMAT Database Logo BIOMAT Database Logo

In vitro combination-effect of temocillin with ticarcillin and aminoglycosides on gram-negative and gram-positive bacteria. 1985

H M Just, and C Becker, and J Gieringer, and A Wenz, and M Bassler, and F Daschner

The in vitro efficacy of temocillin in combination with ticarcillin and with gentamicin, tobramycin, amikacin and netilmicin against 80 Gram-negative and 20 Gram-positive bacterial strains was compared by use of the checkerboard agar dilution technique. No synergistic or additive effect was seen on the Gram-positive strains. Great variations occurred between the different bacterial species, and the temocillin-ticarcillin combination had only little effect against the Pseudomonas strains tested. On average, only 12% of all strains tested were inhibited synergistically by temocillin-gentamicin combinations, and only 7 to 10% by combinations of temocillin with the other aminoglycosides. However, 25% of Gram-negative strains were inhibited synergistically and 40% of Gram-negative strains were inhibited additively by the combination of temocillin-gentamicin.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D013982 Ticarcillin An antibiotic derived from penicillin similar to CARBENICILLIN in action. BRL-2288,Tarcil,Ticar,Ticarcillin Disodium,Ticarpen,Ticillin,BRL 2288,BRL2288,Disodium, Ticarcillin
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

H M Just, and C Becker, and J Gieringer, and A Wenz, and M Bassler, and F Daschner
Combination effect of azthreonam with four aminoglycosides on nosocomial gram-positive cocci and non-fermenting gram-negative bacteria.
December 1982, European journal of clinical microbiology,
H M Just, and C Becker, and J Gieringer, and A Wenz, and M Bassler, and F Daschner
Combination effect of ceftriaxone with four aminoglycosides on nonfermenting gram-negative bacteria.
January 1982, Chemotherapy,
H M Just, and C Becker, and J Gieringer, and A Wenz, and M Bassler, and F Daschner
Combination effect of piperacillin with four aminoglycosides on nonfermenting gram-negative bacteria.
January 1981, Chemotherapy,
H M Just, and C Becker, and J Gieringer, and A Wenz, and M Bassler, and F Daschner
Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria.
January 1991, Infection,
H M Just, and C Becker, and J Gieringer, and A Wenz, and M Bassler, and F Daschner
In-vitro efficacy of cefotiam in combination with four aminoglycosides on staphylococci and Gram-negative bacteria.
September 1981, The Journal of antimicrobial chemotherapy,
H M Just, and C Becker, and J Gieringer, and A Wenz, and M Bassler, and F Daschner
Effect of betamethasone in combination with antibiotics on gram positive and gram negative bacteria.
January 2014, International journal of immunopathology and pharmacology,
H M Just, and C Becker, and J Gieringer, and A Wenz, and M Bassler, and F Daschner
In-vitro activity of ticarcillin with and without clavulanic acid against clinical isolates of gram-positive and gram-negative bacteria.
May 1986, The Journal of antimicrobial chemotherapy,
H M Just, and C Becker, and J Gieringer, and A Wenz, and M Bassler, and F Daschner
In vitro combination effects of cefsulodin, moxalactam and cefoperazone with four aminoglycosides on nonfermenting nosocomial gram-negative bacteria.
January 1982, Arzneimittel-Forschung,
H M Just, and C Becker, and J Gieringer, and A Wenz, and M Bassler, and F Daschner
Effect of human lysozyme on gram-positive and gram-negative bacteria.
January 1968, Antimicrobial agents and chemotherapy,
H M Just, and C Becker, and J Gieringer, and A Wenz, and M Bassler, and F Daschner
Ticarcillin for treatment of serious infections with gram-negative bacteria.
November 1976, The Journal of infectious diseases,
Copied contents to your clipboard!